T. Addissouky

Integrating immunometabolic reprogramming and regulated cell death pathways in sepsis-induced myocardial dysfunction

Macrophage immunometabolic reprogramming constitutes a plausible, predominantly preclinical bridge between systemic cytokine storm and cardiomyocyte energy failure in sepsis, offering therapeutic targets that require prospective validation across precision-stratified populations.